Medical technology is one of Germany's key strategic technologies and ranks among the world's leading industries, second only to the USA. German medical technology, strongly shaped by mid-sized companies, benefits particularly from demographic change and the growing prosperity of older consumers.
Consolida and its partners have played a significant role in developing this market, especially in mobility aids. Through a targeted buy-and-build strategy and the creation of one of the leading manufacturers of these products, we have acted as transaction advisors and subject-matter experts in numerous relevant transactions.
Beyond medical technology, we have also worked in other healthcare sectors such as medical device manufacturing, diagnostic imaging, and care and rehabilitation services. We are thoroughly familiar with the particularities of medical technology, where products and services are closely intertwined, enabling high cross-selling potential and significant consolidation. The market's extensive standardization also promotes international business activity. Innovative products require substantial research and development and are ideally located in Germany. At the same time, comprehensive regulation creates a regional business shaped by national differences.
The market is growing rapidly, resilient to economic downturns and highly profitable. As an active co-investor, Consolida also shares the risks involved in early-stage financing, including in areas such as neurotherapeutic research, diagnostics and biotechnology.